Alpha Paradigm Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-7,566
Closed -$251K – 625
2022
Q2
$251K Sell
7,566
-9,262
-55% -$393K 0.1% 280
2022
Q1
$1.21M Buy
16,828
+12,585
+297% +$907K 0.48% 46
2021
Q4
$390K Sell
4,243
-3,667
-46% -$438K 0.16% 225
2021
Q3
$1M Buy
7,910
+2,370
+43% +$345K 0.4% 62
2021
Q2
$921K Buy
+5,540
New +$898K 0.35% 80
2021
Q1
– Sell
-2,099
Closed -$420K – 627
2020
Q4
$420K Buy
+2,099
New +$427K 0.15% 172

Other funds holding TDOC

Alpha Paradigm Partners's TDOC Position: Q3 2022 in Review

Alpha Paradigm Partners sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 7,566 shares — an estimated $251K sold.

Alpha Paradigm Partners first reported a position in TDOC in Q4 2020 and held it in 6 quarters. The position peaked at $1.21M in Q1 2022. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Alpha Paradigm Partners reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 7,566 Teladoc Health shares in Q3 2022, an estimated $251K.
  • Alpha Paradigm Partners first reported a position in Teladoc Health in Q4 2020 and held it in 6 quarters.
  • Alpha Paradigm Partners's Teladoc Health position peaked at $1.21M in Q1 2022.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.